KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 7 analysts with an average price target of $186.37. This is a potential upside of $42.69 (29.71%) from yesterday's end of day stock price of $143.68.

Krystal Biotech's activity chart (see below) currently has 81 price targets and 89 ratings on display. The stock rating distribution of KRYS is 89.47% BUY and 10.53% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 77.35% with an average time for these price targets to be met of 287.33 days.

Highest price target for KRYS is $240, Lowest price target is $166, average price target is $205.43.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 22-Aug-2025. First documented stock forecast 28-Jun-2018.

Currently out of the existing stock ratings of KRYS, 34 are a BUY (89.47%), 4 are a HOLD (10.53%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$216

$72.32 (50.33%)

$219

23 days ago
(22-Aug-2025)

7/14 (50%)

$65.51 (43.53%)

409

Buy

$240

$96.32 (67.04%)

$240

23 days ago
(22-Aug-2025)

24/37 (64.86%)

$89.51 (59.48%)

210

Hold

$166

$22.32 (15.53%)

$215

1 months 9 days ago
(05-Aug-2025)

1/5 (20%)

$28.65 (20.86%)

135

Buy

$192

$48.32 (33.63%)

$140

1 months 23 days ago
(22-Jul-2025)

2/3 (66.67%)

$40.1 (26.40%)

383

Buy

$189

$45.32 (31.54%)

$175

4 months 7 days ago
(07-May-2025)

4/5 (80%)

$52.2 (38.16%)

135

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 287.33 days on average for the stock forecasts to be realized with a an average price target met ratio 77.35

Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Joseph Pantginis with highest potential upside - $96.32

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with lowest potential downside - -$66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?